Area of research
Epidemiology · Surgery
Research interest
Research interests include Cervical Cancer and HPV Research, Colorectal and Anal Carcinomas, Genital Health and Disease, and Viral-associated cancers and disorders.
Screening for anal cancer in people with HIV- we have the tools to begin.
Anal Human Papillomavirus Infection Progression to Disease Among Men Who Have Sex With Men.
Assessment of Concordant Human Papillomavirus Infection With 9-Valent Vaccine Types Across Anogenital Sites in Young Men.
High Risk of Incident-Persistent Human Papillomavirus Infection With 9-Valent Vaccine Types in Young Men With an HPV Infection.
Prevalence of High-Risk Human Papillomavirus and Associated Risk Factors Among Individuals With Head and Neck Cancer in a National Referral Center in Tanzania.
Expression of Programmed Death-Ligand 1 and Programmed Cell Death-1 Across the Anal Neoplasia Disease Continuum and Association With Survival in Anal Cancer
Screening for Anal Cancer Among Men Who Have Sex With Men With HIV: Benefits, Harms, and Cost-Effectiveness Analyses
Screening for Anal Cancer Among Men Who Have Sex With Men With HIV: Benefits, Harms, and Cost-Effectiveness Analyses.
Strengthening anal cancer prevention in Abuja, Nigeria: Identifying barriers and potential strategies to improve training.
Data from Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer
Supplementary Table S1 from Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer
International Anal Neoplasia Society's consensus guidelines for anal cancer screening
Incidence, Clearance, and Persistence of Penile High-Risk Human Papillomavirus Among Rwandan Men Who Have Sex With Men.
Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (Anal Precancer) Among Women With Human Immunodeficiency Virus.
Data from Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Pre-Cancer
Supplementary Table S1 from Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Pre-Cancer
Programmed death ligand-1 and Programmed cell death protein-1 expression across the anal disease continuum and association with improved survival in anal cancer
Supplementary Table S1 from Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Pre-Cancer
A rapid HPV typing assay to support global cervical cancer screening and risk‐based management: A cross‐sectional study
Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer
State of the science and future directions for research on <scp>HIV</scp> and cancer: Summary of a joint workshop sponsored by <scp>IARC</scp> and <scp>NCI</scp>
COVID-19 as a catalyst for reimagining cervical cancer prevention
Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer.
Cumulative incidence of anal cancer since HIV or AIDS diagnosis in the United States.
COVID-19 as a catalyst for reimagining cervical cancer prevention.
Supplementary Table S1 from Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer
Data from Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer
Supplementary Table S1 from Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer
Supplementary Table S1 from Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer
Supplementary Table S1 from Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer